Rowan University Developing Less Invasive Treatment Options For Pediatric Cancer
September 28, 2022
September 28, 2022
GLASSBORO, New Jersey, Sept. 28 (TNSres) -- Rowan University issued the following news:
Many cancer treatments, like chemotherapy and bone marrow transplants, are invasive and can have severe adverse side effects. A recent $500,000 grant awarded by the N.J. Commission on Cancer Research in the New Jersey Department of Health will support research at Rowan University to develop less invasive and more personalized treatment options for pediatric acute myelogenous leukemia (AML). The p . . .
Many cancer treatments, like chemotherapy and bone marrow transplants, are invasive and can have severe adverse side effects. A recent $500,000 grant awarded by the N.J. Commission on Cancer Research in the New Jersey Department of Health will support research at Rowan University to develop less invasive and more personalized treatment options for pediatric acute myelogenous leukemia (AML). The p . . .